CBO: Disclosure of Drug Pricing Information Could Increase Medicare Costs

CBO: Disclosure of Drug Pricing Information Could Increase Medicare Costs

Public disclosure of drug-pricing information could potentially increase the cost of the Medicare prescription drug benefit by billions of dollars and facilitate “tacit collusion” among drug manufacturers.